ReportsnReports.com adds Datamonitor Market Research Report “Epidemiology: Hypertension – Rising with increasing obesity and population growth’’ to its store.
In this analysis, Datamonitor estimates that there were a total of 210 million cases of hypertension market in 2010 in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK). Prevalence rates for hypertension are expected to grow as a result of increased obesity, sedentary lifestyles, and an increase in the aging population.
Features and benefits
- Gain insight into market potential, including a robust 10-year epidemiology forecast of prevalent hypertension cases.
- Understand the key epidemiologic risk factors associated with hypertension.
Highlights
- Datamonitor expects an increase in hypertension cases through to 2020 in the seven major markets as a result of population growth and rising obesity levels.
- Cardiovascular disorders have severe health implications and increase acute events such as myocardial infarction and stroke.
Table Of Contents
OVERVIEW
Catalyst
Summary
EXECUTIVE SUMMARY
Hypertension will continue to present a leading healthcare burden
DISEASE DEFINITION AND DIAGNOSTIC CRITERIA
Hypertension definition
Hypertension measurement: common biases
Historical and current definitions of hypertension: lowering blood pressure cut-off improved outcome
Pre-hypertension: an intervention for high normal blood pressure
Stages in hypertension: categorize blood pressure based on clinical intervention
Isolated systolic hypertension: the most untreated type of hypertension
ICD codes
GLOBAL VARIATION AND HISTORICAL TRENDS
Global overview: most of the increase is expected in developing countries
Historical trends: the US has the lowest prevalence rates in the seven major markets
Diagnosis rate and awareness: marked improvement in the last 2 decades
Mortality: hypertension is behind leading causes of death worldwide
DRIVERS OF HYPERTENSION EPIDEMIOLOGY
Risk factors
Obesity: the most well-established risk factor
Smoking: important risk factor for acute cardiovascular events
Sodium intake: highest risk factor in developed countries
Co-morbid conditions that alter hypertension epidemiology
Coronary heart disease: common risk factors with hypertension
Renal failure: hypertension undertreatment keeps kidney disease prevalence high
Myocardial infarction: most prevalent and fatal in men
Heart failure: treatment decreases its incidence but does not improve fatality rate
Stroke: main cause of death in hypertensive patients
Diabetes: hypertension increases complications in diabetics
Hypercholesterolemia and dyslipidemia: associated with acute cardiovascular disease
EPIDEMIOLOGIC FORECASTING OF HYPERTENSION
Overview
Data selection
Methods description
Subpopulations
Stages in hypertension
Co-morbidities
US
Sources used
Methods
Japan
Sources used
Methods
France
Sources used
Methods
Sources not used
Germany
Sources used
Methods
Sources not used
Italy
Sources used
Methods
Spain
Sources used
Methods
Sources not used
UK
Sources used
Methods
EPIDEMIOLOGIC RESULTS
Hypertension prevalence will continue to grow over the next decade
Segmentation of prevalent cases in 2010
Age: hypertension increases considerably with age
Sex: insignificant differences between men and women
Majority of hypertension cases are in the lower stage
Diabetes is the most common co-morbidity in hypertensive patients
Age-standardized rates
DISCUSSION
Strengths and limits of Datamonitor’s epidemiologic projections
BIBLIOGRAPHY
Journal papers
Websites
APPENDIX
Module methodology
LIST OF TABLES
Table: Classification of blood pressure for adults aged over 18 years, based on recommendations of the Seventh Joint National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood Pressure, 2003
Table: International Classification of Diseases codes for hypertension
Table: Age-standardized rates of hypertension across various countries and areas in the 1990s
Table: Population-based studies of total hypertension prevalence used in Datamonitor’s forecast
Table: Hypertension prevalence in patients aged over 15 years in the seven major markets (000s), 2010–20
Table: Hypertension prevalence in the seven major markets (000s), by age group, 2010
Table: Hypertension distribution in the seven major markets (%), by age group, 2010
Table: Hypertension prevalence in the seven major markets (000s), by gender, 2010
Table: Hypertension prevalence (000s) in the seven major markets, by stage, 2010
Table: Co-morbidity prevalence in hypertensive patients aged over 15 years in the seven major markets (000s), by disease*, 2010
Table: Age-standardized rates of hypertension in the seven major markets (per 100,000), 2015 and 2020
LIST OF FIGURES
Figure: Percentage of people with hypertension in the seven major markets, by gender, 1990–1999*
Figure: Trends in the number of hypertension deaths in the seven major markets, 1979–2002
Figure: Sales of food-grade salt in the US, 1985–2005
Figure: Health consequences of hypertension
Figure: Hypertension prevalence and stroke mortality rates (per 100,000)* in the seven major markets, 1990–99
Figure: Hypertension prevalence in patients aged over 15 years in the seven major markets (millions), 2010–20
Figure: Age-specific prevalence of hypertension rates in the seven major markets (per 100,000), 2010
Figure: Age-standardized rates of hypertension in the seven major markets (per 100,000), 2010
Latest Market Research Reports:
About Us:
ReportsnReports is an online library of over 75,000 market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
OVERVIEW
Catalyst
Summary
EXECUTIVE SUMMARY
Hypertension will continue to present a leading healthcare burden
DISEASE DEFINITION AND DIAGNOSTIC CRITERIA
Hypertension definition
Hypertension measurement: common biases
Historical and current definitions of hypertension: lowering blood pressure cut-off improved outcome
Pre-hypertension: an intervention for high normal blood pressure
Stages in hypertension: categorize blood pressure based on clinical intervention
Isolated systolic hypertension: the most untreated type of hypertension
ICD codes
GLOBAL VARIATION AND HISTORICAL TRENDS
Global overview: most of the increase is expected in developing countries
Historical trends: the US has the lowest prevalence rates in the seven major markets
Diagnosis rate and awareness: marked improvement in the last 2 decades
Mortality: hypertension is behind leading causes of death worldwide
DRIVERS OF HYPERTENSION EPIDEMIOLOGY
Risk factors
Obesity: the most well-established risk factor
Smoking: important risk factor for acute cardiovascular events
Sodium intake: highest risk factor in developed countries
Co-morbid conditions that alter hypertension epidemiology
Coronary heart disease: common risk factors with hypertension
Renal failure: hypertension undertreatment keeps kidney disease prevalence high
Myocardial infarction: most prevalent and fatal in men
Heart failure: treatment decreases its incidence but does not improve fatality rate
Stroke: main cause of death in hypertensive patients
Diabetes: hypertension increases complications in diabetics
Hypercholesterolemia and dyslipidemia: associated with acute cardiovascular disease
EPIDEMIOLOGIC FORECASTING OF HYPERTENSION
Overview
Data selection
Methods description
Subpopulations
Stages in hypertension
Co-morbidities
US
Sources used
Methods
Japan
Sources used
Methods
France
Sources used
Methods
Sources not used
Germany
Sources used
Methods
Sources not used
Italy
Sources used
Methods
Spain
Sources used
Methods
Sources not used
UK
Sources used
Methods
EPIDEMIOLOGIC RESULTS
Hypertension prevalence will continue to grow over the next decade
Segmentation of prevalent cases in 2010
Age: hypertension increases considerably with age
Sex: insignificant differences between men and women
Majority of hypertension cases are in the lower stage
Diabetes is the most common co-morbidity in hypertensive patients
Age-standardized rates
DISCUSSION
Strengths and limits of Datamonitor’s epidemiologic projections
BIBLIOGRAPHY
Journal papers
Websites
APPENDIX
Module methodology
LIST OF TABLES
Table: Classification of blood pressure for adults aged over 18 years, based on recommendations of the Seventh Joint National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood Pressure, 2003
Table: International Classification of Diseases codes for hypertension
Table: Age-standardized rates of hypertension across various countries and areas in the 1990s
Table: Population-based studies of total hypertension prevalence used in Datamonitor’s forecast
Table: Hypertension prevalence in patients aged over 15 years in the seven major markets (000s), 2010–20
Table: Hypertension prevalence in the seven major markets (000s), by age group, 2010
Table: Hypertension distribution in the seven major markets (%), by age group, 2010
Table: Hypertension prevalence in the seven major markets (000s), by gender, 2010
Table: Hypertension prevalence (000s) in the seven major markets, by stage, 2010
Table: Co-morbidity prevalence in hypertensive patients aged over 15 years in the seven major markets (000s), by disease*, 2010
Table: Age-standardized rates of hypertension in the seven major markets (per 100,000), 2015 and 2020
LIST OF FIGURES
Figure: Percentage of people with hypertension in the seven major markets, by gender, 1990–1999*
Figure: Trends in the number of hypertension deaths in the seven major markets, 1979–2002
Figure: Sales of food-grade salt in the US, 1985–2005
Figure: Health consequences of hypertension
Figure: Hypertension prevalence and stroke mortality rates (per 100,000)* in the seven major markets, 1990–99
Figure: Hypertension prevalence in patients aged over 15 years in the seven major markets (millions), 2010–20
Figure: Age-specific prevalence of hypertension rates in the seven major markets (per 100,000), 2010
Figure: Age-standardized rates of hypertension in the seven major markets (per 100,000), 2010
Latest Market Research Reports:
- The Markets for Flexible Glass – 2011
- Molybdenum Markets in the Electronics and Solar Industries -2011
- Market and Product Forecasts: Top 20 Oncology Therapy Brands - The value of the top 20 decreases as the oncology market fragments
- Food Market Research Bundle: Fats and Oils
- Home Organization in the U.S.: General Purpose, Closets, Garages, and Storage Sheds, 2nd Edition
- The Global Market for Distributed Energy Generation
About Us:
ReportsnReports is an online library of over 75,000 market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689
Contact:
Mr. Priyank
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Visit Our Blog : Market Research Reports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689
Contact:
Mr. Priyank
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Visit Our Blog : Market Research Reports
No comments:
Post a Comment